Publicacións (29) Publicacións nas que participase algún/ha investigador/a

filter_list Critical Care and Intensive Care Medicine

2024

  1. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty

    Angiology, Vol. 75, Núm. 2, pp. 175-181

  2. Guía latinoamericana de recomendaciones al egreso de un síndrome coronario agudo

    Archivos de cardiologia de Mexico, Vol. 94, pp. 1-52

2022

  1. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    BMC Medicine, Vol. 20, Núm. 1

  2. Thirty-second sit-to-stand test as an alternative for estimating peak oxygen uptake and 6-min walking distance in women with breast cancer: a cross-sectional study

    Supportive Care in Cancer, Vol. 30, Núm. 10, pp. 8251-8260

2021

  1. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  2. Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fraction

    Internal Medicine Journal, Vol. 51, Núm. 6, pp. 930-938

2020

  1. A Contemporary Picture of Enterococcal Endocarditis

    Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494

  2. Development and validation of a clinical score to estimate progression to severe or critical state in COVID-19 pneumonia hospitalized patients

    Scientific Reports, Vol. 10, Núm. 1

  3. First-Days Reduction of Plasma and Skin Advanced Glycation End Products is Related to Outcome in Septic Patients

    Shock, Vol. 53, Núm. 4, pp. 400-406

  4. Guía práctica interinstitucional para el tratamiento del infarto agudo de miocardio

    Gaceta medica de Mexico, Vol. 156, Núm. 6, pp. 559-569

2019

  1. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction

    Internal Medicine Journal, Vol. 49, Núm. 12, pp. 1505-1513

  2. Stents farmacoactivos frente a metálicos en pacientes tratados con angioplastia primaria.: Análisis de un registro de 8 años

    REC: Interventional Cardiology, Vol. 1, Núm. 1, pp. 26-33

2018

  1. Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry

    American Journal of Cardiovascular Drugs, Vol. 18, Núm. 4, pp. 299-309

  2. Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score

    International Journal of Cardiology, Vol. 254, pp. 10-15

  3. Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm

    Europace, Vol. 20, Núm. 5, pp. 851-858

2017

  1. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

    Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 176-185

  2. Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure

    International Journal of Cardiology, Vol. 240, pp. 265-270

2015

  1. Perforación de los guantes e infección de la herida de esternotomía en cirugía cardíaca con circulación extracorpórea

    Cirugia Cardiovascular, Vol. 22, Núm. 1, pp. 25-30

2013

  1. Dosing of iodinated contrast volume: A new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome: A New Simple Algorithm to Stratify the Risk of Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome

    Catheterization and Cardiovascular Interventions, Vol. 82, Núm. 6, pp. 888-897

  2. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: Analysis from the SHIFT study

    Clinical Research in Cardiology, Vol. 102, Núm. 1, pp. 11-22